Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schold

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Journal of Neuropathology and Experimental Neurology|July 1, 1981
Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell linesD E Bullard, S C Schold, S H Bigner, et al.
Neurology|May 1, 1984
Treatment of patients with recurrent primary brain tumors with AZQS C Schold, H S Friedman, T D Bjornsson, et al.
Neurosurgery|July 1, 1983
Glioblastoma multiforme after radiotherapy for acromegalyJ H Piatt, J M Blue, S C Schold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Response criteria for phase II studies of supratentorial malignant gliomaD R Macdonald, T L Cascino, S C Schold, et al.
Cancer Treatment Reports|January 1, 1981
How heterogeneous are gliomas?D D Bigner, C Schold, S H Bigner, et al.
Cancer Genetics and Cytogenetics|October 1, 1985
A serially transplantable human giant cell glioblastoma that maintains a near-haploid stem lineS H Bigner, J Mark, S C Schold, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenograftsH S Friedman, P J Houghton, S C Schold, et al.
Annals of Neurology|December 1, 1980
Cerebrospinal fluid biochemical markers of central nervous system metastasesS C Schold, W R Wasserstrom, M Fleisher, et al.
Cancer Genetics and Cytogenetics|July 1, 1989
Chromosomal composition of malignant human gliomas through serial subcutaneous transplantation in athymic miceS H Bigner, S C Schold, H S Friedman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosoureaG M Felker, H S Friedman, M E Dolan, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Journal of Neuropathology and Experimental Neurology|July 1, 1981
Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell linesD E Bullard, S C Schold, S H Bigner, et al.
Neurology|May 1, 1984
Treatment of patients with recurrent primary brain tumors with AZQS C Schold, H S Friedman, T D Bjornsson, et al.
Neurosurgery|July 1, 1983
Glioblastoma multiforme after radiotherapy for acromegalyJ H Piatt, J M Blue, S C Schold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Response criteria for phase II studies of supratentorial malignant gliomaD R Macdonald, T L Cascino, S C Schold, et al.
Cancer Treatment Reports|January 1, 1981
How heterogeneous are gliomas?D D Bigner, C Schold, S H Bigner, et al.
Cancer Genetics and Cytogenetics|October 1, 1985
A serially transplantable human giant cell glioblastoma that maintains a near-haploid stem lineS H Bigner, J Mark, S C Schold, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenograftsH S Friedman, P J Houghton, S C Schold, et al.
Annals of Neurology|December 1, 1980
Cerebrospinal fluid biochemical markers of central nervous system metastasesS C Schold, W R Wasserstrom, M Fleisher, et al.
Cancer Genetics and Cytogenetics|July 1, 1989
Chromosomal composition of malignant human gliomas through serial subcutaneous transplantation in athymic miceS H Bigner, S C Schold, H S Friedman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosoureaG M Felker, H S Friedman, M E Dolan, et al.
Pageof 13